Donovan E, Avila C, Klausner S, Parikh V, Fenollar-Ferrer C, Blakely R
J Neurosci. 2022; 42(16):3426-3444.
PMID: 35232764
PMC: 9034784.
DOI: 10.1523/JNEUROSCI.1334-21.2022.
Wang N, Brickute D, Braga M, Barnes C, Lu H, Allott L
Pharmaceutics. 2021; 13(7).
PMID: 34371769
PMC: 8309005.
DOI: 10.3390/pharmaceutics13071078.
Bhat S, El-Kasaby A, Freissmuth M, Sucic S
Pharmacol Ther. 2020; 222:107785.
PMID: 33310157
PMC: 7612411.
DOI: 10.1016/j.pharmthera.2020.107785.
Parikh V, Bangasser D
Curr Top Behav Neurosci. 2020; 45:71-87.
PMID: 32447715
PMC: 10771779.
DOI: 10.1007/7854_2020_133.
Sarter M, Lustig C
J Neurosci. 2020; 40(4):712-719.
PMID: 31969489
PMC: 6975286.
DOI: 10.1523/JNEUROSCI.1305-19.2019.
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance.
Stout K, Dunn A, Hoffman C, Miller G
ACS Chem Neurosci. 2019; 10(9):3927-3938.
PMID: 31394034
PMC: 11562936.
DOI: 10.1021/acschemneuro.9b00351.
Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.
Wang H, Salter C, Refai O, Hardy H, Barwick K, Akpulat U
Brain. 2017; 140(11):2838-2850.
PMID: 29088354
PMC: 5844214.
DOI: 10.1093/brain/awx249.
Nicotinic modulation of descending pain control circuitry.
Umana I, Daniele C, Miller B, Abburi C, Gallagher K, Brown M
Pain. 2017; 158(10):1938-1950.
PMID: 28817416
PMC: 5873975.
DOI: 10.1097/j.pain.0000000000000993.
Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.
Cherian A, Parikh V, Wu Q, Mao-Draayer Y, Wang Q, Blakely R
Neurochem Int. 2017; 108:410-416.
PMID: 28577989
PMC: 5524217.
DOI: 10.1016/j.neuint.2017.05.022.
Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter.
Choudhary P, Armstrong E, Jorgensen C, Piotrowski M, Barthmes M, Torella R
Front Mol Neurosci. 2017; 10:40.
PMID: 28289374
PMC: 5326799.
DOI: 10.3389/fnmol.2017.00040.
Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.
Cherian A, Kucinski A, Pitchers K, Yegla B, Parikh V, Kim Y
J Neurosci. 2017; 37(11):2947-2959.
PMID: 28193693
PMC: 5354335.
DOI: 10.1523/JNEUROSCI.3499-16.2017.
Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.
Kim K, Muller M, Bohnen N, Sarter M, Lustig C
Neuroimage. 2017; 149:295-304.
PMID: 28167350
PMC: 5386784.
DOI: 10.1016/j.neuroimage.2017.02.006.
Cholinergic genetics of visual attention: Human and mouse choline transporter capacity variants influence distractibility.
Sarter M, Lustig C, Blakely R, Cherian A
J Physiol Paris. 2016; 110(1-2):10-18.
PMID: 27404793
PMC: 5164965.
DOI: 10.1016/j.jphysparis.2016.07.001.
Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine.
Iwamoto H, Calcutt M, Blakely R
Neurochem Int. 2016; 98:138-45.
PMID: 27013347
PMC: 4969175.
DOI: 10.1016/j.neuint.2016.03.012.
Age-related attenuation of parasympathetic control of the heart in mice.
Freeling J, Li Y
Int J Physiol Pathophysiol Pharmacol. 2016; 7(3):126-35.
PMID: 26823961
PMC: 4697668.
Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter.
Bollinger S, Engers D, Ennis E, Wright J, Locuson C, Lindsley C
Bioorg Med Chem Lett. 2015; 25(8):1757-1760.
PMID: 25801932
PMC: 4385452.
DOI: 10.1016/j.bmcl.2015.02.058.
Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects.
Yegla B, Parikh V
Front Syst Neurosci. 2015; 8:254.
PMID: 25674054
PMC: 4309160.
DOI: 10.3389/fnsys.2014.00254.
Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporter.
Ennis E, Wright J, Retzlaff C, McManus O, Lin Z, Huang X
ACS Chem Neurosci. 2015; 6(3):417-27.
PMID: 25560927
PMC: 4367188.
DOI: 10.1021/cn5001809.
Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities.
Parikh V, Bernard C, Naughton S, Yegla B
Behav Brain Res. 2014; 274:30-42.
PMID: 25101540
PMC: 4179990.
DOI: 10.1016/j.bbr.2014.07.046.
Functional expression of α7-nicotinic acetylcholine receptors by muscle afferent neurons.
Baxter J, Ramachandra R, Mayne D, Elmslie K
J Neurophysiol. 2014; 112(6):1549-58.
PMID: 24966300
PMC: 4137244.
DOI: 10.1152/jn.00035.2014.